AI-generated summary
The authors studied a 755-nm picosecond alexandrite laser with a diffractive lens array in 18 Chinese patients with mild to moderate facial photoaging, in a prospective, evaluator-blinded trial. They report improvement in skin texture and dyspigmentation that was sustained at 3 months, with no significant change in pore size, rhytides, or skin laxity, and mainly transient erythema and edema as side effects.
- Participants
- 18
- Who or what was studied
- Chinese patients aged 35 to 59 with Fitzpatrick skin types III-IV and mild to moderate facial photoaging
- Wavelengths
- 755 nm
- Limits stated in the abstract
- The abstract reports a small sample of 18 patients, and the conclusion of safety and effectiveness is drawn from a single prospective trial with no control group stated.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Visual analogue scale. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.